Invesco Ltd. 10x Genomics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 96,933 shares of TXG stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

96,933

Previous 100,418 3.47%

Holding current value

$1.53 Million

Previous $1.95 Million 12.03%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.71 - $23.49 $54,749 - $81,862	-3,485 Reduced 3.47%	96,933 $2.19 Million
Q2 2024 Aug 13, 2024	BUY	$19.45 - $37.37 $323,006 - $620,603	16,607 Added 19.81%	100,418 $1.95 Million
Q1 2024 May 14, 2024	SELL	$36.08 - $54.3 $81.2 Million - $122 Million	-2,251,127 Reduced 96.41%	83,811 $3.15 Million
Q4 2023 Feb 12, 2024	BUY	$34.32 - $57.55 $3.72 Million - $6.24 Million	108,472 Added 4.87%	2,334,938 $131 Million
Q3 2023 Nov 13, 2023	BUY	$40.86 - $62.98 $14.5 Million - $22.3 Million	354,680 Added 18.95%	2,226,466 $91.8 Million
Q2 2023 Aug 11, 2023	BUY	$50.96 - $58.72 $10.4 Million - $12 Million	204,123 Added 12.24%	1,871,786 $105 Million
Q1 2023 May 12, 2023	BUY	$35.33 - $55.79 $56.2 Million - $88.7 Million	1,590,355 Added 2057.17%	1,667,663 $93 Million
Q4 2022 Feb 13, 2023	SELL	$24.4 - $41.3 $1.31 Million - $2.21 Million	-53,570 Reduced 40.93%	77,308 $2.82 Million
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $70,687 - $130,528	2,482 Added 1.93%	130,878 $3.73 Million
Q2 2022 Aug 15, 2022	SELL	$36.95 - $82.41 $210,430 - $469,324	-5,695 Reduced 4.25%	128,396 $5.81 Million
Q1 2022 May 16, 2022	SELL	$55.7 - $145.79 $2.62 Million - $6.87 Million	-47,119 Reduced 26.0%	134,091 $10.2 Million
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $50 Million - $67.6 Million	-370,446 Reduced 67.15%	181,210 $27 Million
Q3 2021 Nov 15, 2021	SELL	$145.58 - $192.14 $95.6 Million - $126 Million	-656,798 Reduced 54.35%	551,656 $80.3 Million
Q2 2021 Aug 17, 2021	SELL	$134.22 - $202.37 $12.7 Million - $19.2 Million	-94,878 Reduced 7.28%	1,208,454 $237 Million
Q1 2021 May 17, 2021	BUY	$140.25 - $196.86 $27.8 Million - $39 Million	198,217 Added 17.94%	1,303,332 $236 Million
Q4 2020 Feb 16, 2021	SELL	$126.47 - $163.7 $87 Million - $113 Million	-687,718 Reduced 38.36%	1,105,115 $156 Million
Q3 2020 Nov 16, 2020	BUY	$87.44 - $125.0 $41.8 Million - $59.8 Million	478,366 Added 36.39%	1,792,833 $224 Million
Q2 2020 Aug 14, 2020	BUY	$58.39 - $89.31 $3.47 Million - $5.31 Million	59,445 Added 4.74%	1,314,467 $117 Million
Q1 2020 May 15, 2020	BUY	$51.57 - $106.62 $40.8 Million - $84.3 Million	790,769 Added 170.33%	1,255,022 $78.2 Million
Q4 2019 Feb 14, 2020	BUY	$46.07 - $79.54 $4.78 Million - $8.25 Million	103,661 Added 28.75%	464,253 $35.4 Million
Q3 2019 Nov 14, 2019	BUY	$49.99 - $62.0 $18 Million - $22.4 Million	360,592 New	360,592 $18.2 Million

Others Institutions Holding TXG

# of Institutions

291

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account